Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.
The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.
Links to related guidelines are provided separately. (See "Society guideline links: Adult with chest pain in the emergency department".)
International
●American College of Cardiology (ACC)/American Heart Association (AHA)/American Society of Echocardiography (ASE)/American Society of Nuclear Cardiology (ASNC)/American Society of Preventive Cardiology (ASPC)/Heart Failure Society of America (HFSA)/Heart Rhythm Society (HRS)/Society for Cardiovascular Angiography and Interventions (SCAI)/Society of Cardiovascular Computed Tomography (SCCT)/Society for Cardiovascular Magnetic Resonance (SCMR)/Society of Thoracic Surgeons (STS): Multimodality appropriate use criteria for the detection and risk assessment of chronic coronary disease (2023)
Canada
●Choosing Wisely Canada: Don't order screening chest X-rays and ECGs for asymptomatic or low risk outpatients (2023)
●Choosing Wisely Canada: Don't order annual electrocardiograms (ECGs) for low-risk patients without symptoms (2022)
●Choosing Wisely Canada: Don't order or refer for percutaneous coronary intervention in patients with stable coronary artery disease that do not have high risk features, and are asymptomatic or have not been on optimal medical therapy (2022)
●Choosing Wisely Canada: Don't perform annual stress cardiac imaging or advanced non-invasive imaging as part of routine follow-up in asymptomatic patients (2022)
●Choosing Wisely Canada: Don't perform stress cardiac imaging or advanced non-invasive imaging as a pre-operative assessment in patients scheduled to undergo low-risk non-cardiac surgery (2022)
●Choosing Wisely Canada: Don't perform stress cardiac imaging or advanced non-invasive imaging in the initial evaluation of patients without cardiac symptoms unless high-risk markers are present (2022)
●Choosing Wisely Canada: Don't transfuse red blood cells for arbitrary hemoglobin or hematocrit thresholds in the absence of symptoms, active coronary disease, heart failure or stroke (2022)
●Canadian Cardiovascular Society (CCS)/Canadian Heart Failure Society (CHFS): Heart failure guidelines update – Defining a new pharmacologic standard of care for heart failure with reduced ejection fraction (2021)
●Choosing Wisely Canada: Don't perform cardiac stress testing for asymptomatic patients undergoing low to intermediate risk non-cardiac surgery (2020)
●CCS: Guidelines for the diagnosis and management of stable ischemic heart disease (2014)
●CCS/Canadian Association of Interventional Cardiology (CAIC)/Canadian Society of Cardiac Surgery (CSCS): Position statement on revascularization − Multivessel coronary artery disease (2014)
●CCS/Canadian Pain Society (CPS): Joint guidelines for the management of patients with refractory angina (2012)
United States
●American College of Cardiology (ACC)/American Heart Association (AHA)/American Society of Echocardiography (ASE)/American Society of Nuclear Cardiology (ASNC)/American Society of Preventive Cardiology (ASPC)/Heart Failure Society of America (HFSA)/Heart Rhythm Society (HRS)/Society for Cardiovascular Angiography and Interventions (SCAI)/Society of Cardiovascular Computed Tomography (SCCT)/Society for Cardiovascular Magnetic Resonance (SCMR)/Society of Thoracic Surgeons (STS): Multimodality appropriate use criteria for the detection and risk assessment of chronic coronary disease (2023)
●AHA/ACC: Clinical performance and quality measures for coronary artery revascularization (2023)
●AHA/ACC/American College of Clinical Pharmacy (ACCP)/ASPC/National Lipid Association (NLA)/Preventive Cardiovascular Nurses Association (PCNA): Guideline for the management of patients with chronic coronary disease (2023)
●European Association of Cardiovascular Imaging (EACVI) and American Society of Echocardiography (ASE): Recommendations on non-invasive imaging in coronary syndromes (2022)
●SCCT, ACC, American College of Radiology (ACR), and North America Society of Cardiovascular Imaging (NASCI): Expert consensus document on CAD-RADS™ 2.0 – 2022 Coronary Artery Disease-Reporting and Data System (2022)
●ACC/AHA/SCAI: Guideline for coronary artery revascularization (2021)
●ACR: ACR Appropriateness Criteria on chronic chest pain – High probability of coronary artery disease (revised 2021)
●ACR: ACR Appropriateness Criteria on acute nonspecific chest pain – Low probability of coronary artery disease (revised 2020)
●ACR: ACR Appropriateness Criteria on asymptomatic patient at risk for coronary artery disease (revised 2020)
●AHA: Scientific statement on clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus (2020)
●ACR: ACR Appropriateness Criteria on chest pain – Possible acute coronary syndrome (revised 2019)
●ACR: ACR Appropriateness Criteria on chronic chest pain – Noncardiac etiology unlikely: Low to intermediate probability of coronary artery disease (revised 2018)
●SCCT: An expert consensus document on CAC-DRS − Coronary artery calcium data and reporting system (2018)
●ACC/American Association for Thoracic Surgery (AATS)/AHA/ASE/ASNC/SCAI/SCCT/STS: Appropriate use criteria for coronary revascularization in patients with acute coronary syndromes (2017)
●ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS: Appropriate use criteria for coronary revascularization in patients with stable ischemic heart disease (2017)
●ASNC: Consensus statement on myocardial perfusion imaging in women for the evaluation of stable ischemic heart disease − State-of-the-evidence and clinical recommendations (2017)
●ACC/AHA: Guideline on duration of dual antiplatelet therapy in patients with coronary artery disease, focused update (2016)
●ASNC: Imaging guidelines for SPECT nuclear cardiology procedures − Stress, protocols, and tracers (2016)
●ASNC/Society of Nuclear Medicine and Molecular Imaging (SNMMI): Joint position statement on the clinical indications for myocardial perfusion PET (2016)
●AHA, ACC, and American Society of Hypertension (ASH): A scientific statement for the treatment of hypertension in patients with coronary artery disease (2015)
●AHA: A consensus statement on the role of noninvasive testing in the clinical evaluation of women with suspected ischemic heart disease (2014)
●American College of Cardiology Foundation (ACCF)/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS: 2013 multimodality appropriate use criteria for the detection and risk assessment of stable ischemic heart disease (2014)
●SNMMI/ASNC/SCCT: Guideline for cardiac SPECT/CT and PET/CT 1.0 (2013)
Europe
●European Association of Cardiovascular Imaging (EACVI) and American Society of Echocardiography (ASE): Recommendations on non-invasive imaging in coronary syndromes (2022)
●European Association of Percutaneous Cardiovascular Interventions (EAPCI): Expert consensus document on ischaemia with non-obstructive coronary arteries (2020)
●European Society of Cardiology (ESC): Guidelines on chronic coronary syndromes (2019)
●ESC/European Association for Cardio-Thoracic Surgery (EACTS): Guidelines on myocardial revascularization (2018)
United Kingdom
●National Institute for Health and Care Excellence (NICE): Interventional procedures guidance on bioresorbable stent implantation for treating coronary artery disease (2022)
●Scottish Intercollegiate Guidelines Network (SIGN): A national clinical guideline on cardiac rehabilitation (2017, reviewed 2021)
●NICE: Guideline on acute coronary syndromes (2020)
●Scottish Intercollegiate Guidelines Network (SIGN): A national clinical guideline on management of stable angina (2018)
●NICE: Quality standard on stable angina (2012, updated 2017)
●NICE: Clinical guideline on recent-onset chest pain of suspected cardiac origin − Assessment and diagnosis (2010, updated 2016)
●NICE: Clinical guideline on stable angina − Management (2011, updated 2016)
Australia–New Zealand
●National Heart Foundation of Australia: Position statement on coronary artery calcium scoring for the primary prevention of cardiovascular disease in Australia (2021)
●Cardiac Society of Australia and New Zealand (CSANZ): Coronary artery calcium scoring − Position statement (2017)
●CSANZ: Position statement – Clinical exercise stress testing in adults (2014)
Japan
●[In Japanese] Japanese Circulation Society (JCS): Guideline on the primary prevention of coronary artery disease (2023)
●[In English] JCS/Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT)/Japanese College of Cardiology (JCC): Guideline on diagnosis and treatment of vasospastic angina (coronary spastic angina) and coronary microvascular dysfunction, focused update (2023)
●[In Japanese] JCS/CVIT/JCC: Guideline on diagnosis and treatment of vasospastic angina (coronary spastic angina) and coronary microvascular dysfunction, focused update (2023)
●[In English] JCS: Guideline on diagnosis and treatment in patients with stable coronary artery disease, focused update (2022)
●[In Japanese] JCS: Guideline on diagnosis and treatment in patients with stable coronary artery disease, focused update (2022)
●[In English] JCS: Guideline on antithrombotic therapy in patients with coronary artery disease, focused update (2020)
●[In Japanese] JCS: Guideline on antithrombotic therapy in patients with coronary artery disease, focused update (2020)
●[In English] JCS: Guideline on diagnosis of chronic coronary heart diseases (2018)
●[In Japanese] JCS: Guideline on diagnosis of chronic coronary heart diseases (2018)
●[In Japanese] JCS: Guideline on revascularization of stable coronary artery disease (2018)
●[In English] JCS/Japanese Society for Cardiovascular Surgery (JSCVS): Guideline on revascularization of stable coronary artery disease (2018)
